Correlation Between GeneFerm Biotechnology and Alar Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both GeneFerm Biotechnology and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneFerm Biotechnology and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneFerm Biotechnology Co and Alar Pharmaceuticals, you can compare the effects of market volatilities on GeneFerm Biotechnology and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneFerm Biotechnology with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneFerm Biotechnology and Alar Pharmaceuticals.
Diversification Opportunities for GeneFerm Biotechnology and Alar Pharmaceuticals
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between GeneFerm and Alar is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding GeneFerm Biotechnology Co and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and GeneFerm Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneFerm Biotechnology Co are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of GeneFerm Biotechnology i.e., GeneFerm Biotechnology and Alar Pharmaceuticals go up and down completely randomly.
Pair Corralation between GeneFerm Biotechnology and Alar Pharmaceuticals
Assuming the 90 days trading horizon GeneFerm Biotechnology is expected to generate 16.9 times less return on investment than Alar Pharmaceuticals. But when comparing it to its historical volatility, GeneFerm Biotechnology Co is 1.61 times less risky than Alar Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Alar Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 10,144 in Alar Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 4,856 from holding Alar Pharmaceuticals or generate 47.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.79% |
| Values | Daily Returns |
GeneFerm Biotechnology Co vs. Alar Pharmaceuticals
Performance |
| Timeline |
| GeneFerm Biotechnology |
| Alar Pharmaceuticals |
GeneFerm Biotechnology and Alar Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GeneFerm Biotechnology and Alar Pharmaceuticals
The main advantage of trading using opposite GeneFerm Biotechnology and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneFerm Biotechnology position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.| GeneFerm Biotechnology vs. Center Laboratories | GeneFerm Biotechnology vs. Handa Pharmaceuticals | GeneFerm Biotechnology vs. DV Biomed Co | GeneFerm Biotechnology vs. Alar Pharmaceuticals |
| Alar Pharmaceuticals vs. Loop Telecommunication International | Alar Pharmaceuticals vs. Taiwan Mobile Co | Alar Pharmaceuticals vs. Energenesis Biomedical Co | Alar Pharmaceuticals vs. Tai Tung Communication |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |